JP2022532431A5 - - Google Patents

Info

Publication number
JP2022532431A5
JP2022532431A5 JP2021568694A JP2021568694A JP2022532431A5 JP 2022532431 A5 JP2022532431 A5 JP 2022532431A5 JP 2021568694 A JP2021568694 A JP 2021568694A JP 2021568694 A JP2021568694 A JP 2021568694A JP 2022532431 A5 JP2022532431 A5 JP 2022532431A5
Authority
JP
Japan
Prior art keywords
item
inhalable formulation
imatinib
salt
inhalable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568694A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532431A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/032872 external-priority patent/WO2020232236A1/en
Publication of JP2022532431A publication Critical patent/JP2022532431A/ja
Publication of JP2022532431A5 publication Critical patent/JP2022532431A5/ja
Pending legal-status Critical Current

Links

JP2021568694A 2019-05-16 2020-05-14 イマチニブ製剤、その製造および使用 Pending JP2022532431A (ja)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US201962849058P 2019-05-16 2019-05-16
US201962849054P 2019-05-16 2019-05-16
US201962849056P 2019-05-16 2019-05-16
US201962849059P 2019-05-16 2019-05-16
US62/849,054 2019-05-16
US62/849,059 2019-05-16
US62/849,056 2019-05-16
US62/849,058 2019-05-16
US201962877575P 2019-07-23 2019-07-23
US62/877,575 2019-07-23
US201962942408P 2019-12-02 2019-12-02
US62/942,408 2019-12-02
US202062958481P 2020-01-08 2020-01-08
US62/958,481 2020-01-08
US202062984037P 2020-03-02 2020-03-02
US62/984,037 2020-03-02
PCT/US2020/032872 WO2020232236A1 (en) 2019-05-16 2020-05-14 Imatinib formulations, manufacture, and uses thereof

Publications (2)

Publication Number Publication Date
JP2022532431A JP2022532431A (ja) 2022-07-14
JP2022532431A5 true JP2022532431A5 (https=) 2023-05-12

Family

ID=73228465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021568694A Pending JP2022532431A (ja) 2019-05-16 2020-05-14 イマチニブ製剤、その製造および使用

Country Status (14)

Country Link
US (13) US20200360477A1 (https=)
EP (2) EP3968963A4 (https=)
JP (1) JP2022532431A (https=)
KR (1) KR20220050839A (https=)
CN (1) CN114514016A (https=)
AU (1) AU2020274521A1 (https=)
BR (1) BR112021023014A2 (https=)
CA (1) CA3140641A1 (https=)
IL (1) IL288111A (https=)
JO (1) JOP20210305A1 (https=)
MX (1) MX2021014029A (https=)
SG (1) SG11202112719XA (https=)
WO (2) WO2020232236A1 (https=)
ZA (1) ZA202109070B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3782604A1 (en) 2013-07-31 2021-02-24 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
US20200360477A1 (en) * 2019-05-16 2020-11-19 Aerovate Therapeutics, Inc. Inhalable formulations for kinase inhibition
CN116916889A (zh) * 2020-11-17 2023-10-20 联合治疗公司 用于肺高压领域的吸入式伊马替尼
EP4247378A4 (en) * 2020-11-23 2024-08-14 Aerovate Therapeutics, Inc. IMATINIB FORMULATIONS, MANUFACTURE AND USES THEREOF
CN117098557A (zh) * 2020-11-23 2023-11-21 埃渃维特治疗学公司 伊马替尼调配物、其制备和用途
CA3204054A1 (en) * 2021-01-06 2022-07-14 Carlos Schuler Inhalable imatinib formulation
CN117157076A (zh) * 2021-02-15 2023-12-01 埃渃维特治疗学公司 可吸入伊马替尼调配物、其制造和用途
KR102634754B1 (ko) * 2021-07-07 2024-02-08 애니머스큐어 주식회사 이마티닙을 포함하는 근육 질환의 예방 또는 치료용 조성물
EP4472609A1 (en) * 2022-02-04 2024-12-11 Justus-Liebig-Universität Gießen Inhaled imatinib for treatment of pulmonary hypertension

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
JP4484247B2 (ja) * 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
GB0009468D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
WO2004004644A2 (en) * 2002-07-05 2004-01-15 Beth Israel Deaconess Medical Center Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms
GB2398565A (en) 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
US20040204439A1 (en) 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
ATE481134T1 (de) 2004-01-21 2010-10-15 Univ Emory Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
US7507821B2 (en) 2004-12-30 2009-03-24 Chemagis Ltd. Process for preparing Imatinib
SI1833815T1 (sl) 2004-12-30 2011-01-31 Inst Farmaceutyczny Postopek priprave baze imatiniba
EP1695728A1 (de) 2005-02-23 2006-08-30 Activaero GmbH Bauteil für eine Inhalationsvorrichtung, Inhalationsvorrichtung mit diesem Bauteil und Steuerverfahren für ein solches Bauteil
EP1700614B1 (de) 2005-03-08 2013-05-08 Activaero GmbH Inhalationsvorrichtung
EA015102B1 (ru) * 2005-06-03 2011-06-30 Элан Фарма Интернэшнл Лтд. Препараты наночастиц мезилата иматиниба
ATE373498T1 (de) 2005-07-06 2007-10-15 Activaero Gmbh Regelbares ventil und inhalationsvorrichtung
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
CA2550702A1 (en) 2006-03-24 2007-09-24 Kensuke Egashira Organic compounds
US20060223817A1 (en) * 2006-05-15 2006-10-05 Chemagis Ltd. Crystalline imatinib base and production process therefor
WO2008011051A1 (en) 2006-07-17 2008-01-24 Liquidia Technologies, Inc. Nanoparticle fabrication methods, systems, and materials
EP2009008A1 (en) * 2006-10-26 2008-12-31 Sicor, Inc. Imatinib base, and imatinib mesylate and processes for preparation thereof
WO2008057291A2 (en) * 2006-10-26 2008-05-15 Sicor Inc. Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof
US20130177598A1 (en) * 2007-02-27 2013-07-11 The University Of North Carolina At Chapel Hill Discrete size and shape specific pharmaceutical organic nanoparticles
WO2008136010A1 (en) 2007-05-07 2008-11-13 Natco Pharma Limited A process for the preparation of highly pure imatinib base
EP2179291B1 (en) 2007-07-13 2014-10-22 Nestec S.A. Drug selection for lung cancer therapy using antibody-based arrays
ES2398921T3 (es) 2007-08-02 2013-03-22 Activaero Gmbh Dispositivo y sistema para dirigir partículas aerosolizadas a un área específica de los pulmones
EP2033674A1 (de) 2007-09-06 2009-03-11 Activaero GmbH Inhalationsgerät
KR20110053354A (ko) 2008-08-13 2011-05-20 노파르티스 아게 폐동맥 고혈압의 치료
US8834848B2 (en) 2009-02-04 2014-09-16 Activaero Gmbh Research & Development Flow and volume regulated inhalation for treatment of severe oral corticosteroid-dependent asthma
US20100330130A1 (en) 2009-05-22 2010-12-30 Actavis Group Ptc Ehf Substantially pure imatinib or a pharmaceutically acceptable salt thereof
CZ2009570A3 (cs) 2009-08-26 2011-03-09 Zentiva, K. S. Príprava, stabilizace a využití polymorfu imatinib mesylátu pro vývoj lékových forem
US20130034534A1 (en) 2009-09-29 2013-02-07 Philipp Kroneberg Method for treatment of patients with cystic fibrosis
WO2011039782A1 (en) 2009-09-29 2011-04-07 Ind-Swift Laboratories Limited Processes for preparing imatinib and pharmaceutically acceptable salts thereof
US20110306763A1 (en) 2009-12-10 2011-12-15 Shanghai Parling Pharmatech Co., Ltd. Process for the preparation of imatinib and salts thereof
WO2011095835A1 (en) 2010-02-02 2011-08-11 Actavis Group Ptc Ehf Highly pure imatinib or a pharmaceutically acceptable salt thereof
WO2011100282A2 (en) 2010-02-09 2011-08-18 Dr. Reddy's Laboratories Ltd. Imatinib mesylate polymorphs
KR20130055576A (ko) * 2010-03-15 2013-05-28 낫코 파마 리미티드 고순도의 결정질 이마티닙 염기를 제조하는 방법
EA024088B1 (ru) * 2010-06-18 2016-08-31 КРКА, д.д., НОВО МЕСТО α-ФОРМА МЕЗИЛАТА ИМАТИНИБА, СПОСОБЫ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЁ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
TR201007005A2 (tr) 2010-08-23 2011-09-21 Mustafa Nevzat İlaç Sanayi̇i̇ A.Ş. İmatinib baz üretim yöntemi
WO2012090221A1 (en) * 2010-12-29 2012-07-05 Cadila Healthcare Limited Novel salts of imatinib
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
PT2701683T (pt) 2011-04-26 2017-05-03 Vectura Gmbh Administração de iloprost como bólus de aerossol
EP2724741B1 (en) 2012-10-26 2017-06-14 Vectura GmbH Inhalation device for use in aerosol therapy
EP2846859B1 (en) 2012-03-09 2017-01-04 Vectura GmbH Mixing channel for an inhalation device and inhalation device
CN103570676B (zh) * 2012-08-04 2016-03-16 正大天晴药业集团股份有限公司 甲磺酸伊马替尼α结晶的制备及其药物组合物
EP2895146A1 (en) * 2012-09-17 2015-07-22 BIND Therapeutics, Inc. Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
WO2014067699A1 (en) 2012-10-31 2014-05-08 Activaero Gmbh Administration of aerosolised iloprost
ES2675720T3 (es) 2013-01-10 2018-07-12 Pulmokine, Inc. Inhibidores de quinasa no selectivos
EP2988738A4 (en) * 2013-01-10 2016-11-09 Pulmokine Inc THERAPEUTIC INDICATIONS OF KINASE INHIBITORS
EP3782604A1 (en) * 2013-07-31 2021-02-24 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
JP6401273B2 (ja) 2013-08-16 2018-10-10 ベクチュラ・ゲーエムベーハー 吸入装置用投与システム
US9925184B2 (en) 2013-10-11 2018-03-27 Pulmokine, Inc. Spray-dry formulations
AU2015204558B2 (en) 2014-01-10 2020-04-30 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
CN103910711A (zh) * 2014-03-24 2014-07-09 福建天泉药业股份有限公司 一种伊马替尼游离碱晶型及其制备方法
WO2015188243A1 (en) * 2014-06-10 2015-12-17 Cristália Produtos Químicos Farmacêuticos Ltda PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
US10561805B2 (en) 2014-10-10 2020-02-18 Ablynx N.V. Methods of treating RSV infections
KR20180050320A (ko) 2015-09-09 2018-05-14 노파르티스 아게 분무-건조된 제제의 폐로의 표적화된 전달
EP3689339B1 (en) 2015-09-09 2022-01-26 Vectura Limited Jet milling method
AU2017351638A1 (en) 2016-10-26 2019-06-13 Genea Biocells USA (Holdings), Inc. Improved generation of muscle lineage cells and therapeutic uses thereof
US10788268B2 (en) 2017-09-19 2020-09-29 Evapco, Inc. Air-cooled heat transfer device with integrated and mechanized air pre-cool system
EP3841090A4 (en) 2018-08-22 2022-10-19 Avalyn Pharma Inc. SPECIALLY FORMULATED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS
US20200360477A1 (en) * 2019-05-16 2020-11-19 Aerovate Therapeutics, Inc. Inhalable formulations for kinase inhibition
US11464776B2 (en) 2019-05-16 2022-10-11 Aerovate Therapeutics, Inc. Inhalable imatinib formulations, manufacture, and uses thereof

Similar Documents

Publication Publication Date Title
JP2022532431A5 (https=)
AU742385B2 (en) Microparticles and their therapeutic or diagnostic use
JP6857467B2 (ja) 医薬品有効成分の粒子加工のための方法
CA2523475C (en) Pharmaceutical formulation comprising a water-insoluble active agent
CA1089364A (en) Orally administrable pharmaceutical composition
Manu et al. Spray drying in pharmaceutical industry: A review
TWI436994B (zh) 製備含有達比加群（ｄａｂｉｇａｔｒａｎ）之藥物組合物的新穎方法
US12233163B2 (en) Crystalline microspheres and the process of manufacturing the same
JP7236485B2 (ja) 三流体ノズルを用いた吸入用複合粒子の製造方法
JPH02180813A (ja) 顆粒状製剤
TW200817047A (en) Drug microparticles
JP2017532374A5 (https=)
JP6883039B2 (ja) 呼吸域ザフィルルカスト粒子の調製方法
RU2018112077A (ru) Направленная доставка высушенных распылением композиций в легкие
US20030188679A1 (en) Powdered mannitol and mannitol-containing compositions
Yang et al. Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers
KR20030081507A (ko) 메토프롤롤을 함유하는 미립자의 제조 방법
KR102342819B1 (ko) 마이크로 점적 환제의 제형 및 이의 제조방법
JP2012025683A (ja) 苦味を有する生理活性物質含有粒子の製造方法
CN115252536A (zh) 一种用于治疗特发性肺纤维化的二甲双胍吸入粉雾剂及其制备方法
JPH04202124A (ja) 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
WO2002024175A2 (en) Pharmaceutical formulation for pulmonary or nasal administration
CN106309405A (zh) 一种功能性细微丸的制备方法
Srinivas Spray Drying in Pharmaceutical Manufacturing an Overview
CN108619118A (zh) 一种肺部吸入用布地奈德自组装胶束